CXCL17 and lung cancer: In the present study, using clinical samples, overexpression and knockdown approaches in lung cancer cell lines, and mouse tumor models, we identified a molecular mechanism involving the OCT4-VCC-1 signaling axis in lung cancer (Figure 5C).